← All trials
NCT05168813
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2021
- Primary completion
- Jun 1, 2023
- Completion date
- Apr 24, 2024
- First posted
- Dec 23, 2021
- Last posted
- Oct 3, 2022
- Enrollment
- 14232
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- COVID-19 Prevention NetworkLead sponsor
- Johns Hopkins UniversityStudy chair
- Centre for the AIDS Programme of Research in South AfricaStudy chair
- Medical Research Council, South AfricaCollaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- Qhakaza Mbokodo Research ClinicStudy chair
- Johns Hopkins UniversityOfficial
- Qhakaza Mbokodo Research ClinicOfficial
- Centre for the AIDS Programme of Research in South AfricaOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.